THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS
Pathum Sookaromdee, Viroj Wiwanitkit.
PDF Görünüm
Referanslar
- 1. Hsia W. Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep 2020;10:8-9. google scholar
- 2. Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021;20(1):23-44. [CrossRef] google scholar
- 3. Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 Vaccine booster: to boost or not to boost. Infect Dis Rep 2021;13(4):924-929. [CrossRef] google scholar
- 4. Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021;398(10308):1377-80. [CrossRef] google scholar
- 5. Mahase E. COVID-19: third vaccine dose boosts immune response but may not be needed, say researchers. BMJ 2021;373:n1659. [CrossRef] google scholar
- 6. Burki TK. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir Med 2022;10(2):e19. [CrossRef] google scholar
- 7. Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, et al. Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation 2022;106(5):e262-3. [CrossRef] google scholar
- 8. Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J Clin Med 2022;11(9):2565. [CrossRef] google scholar
- 9. Sookaromdee P, Wiwanitkit V. New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis. Arch Med Res 2021;52(4):453. [CrossRef] google scholar
- 10. Yasri S, Wiwanitkit V. Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background. Int J Physiol Pathophysiol Pharmacol 2022;14(1):1-3. google scholar
Atıflar
Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın
DIŞA AKTAR
APA
Sookaromdee, P., & Wiwanitkit, V. (2022). THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İstanbul Tıp Fakültesi Dergisi, 85(4), 585-586. https://doi.org/10.26650/IUITFD.1133431
AMA
Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İstanbul Tıp Fakültesi Dergisi. 2022;85(4):585-586. https://doi.org/10.26650/IUITFD.1133431
ABNT
Sookaromdee, P.; Wiwanitkit, V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İstanbul Tıp Fakültesi Dergisi, [Publisher Location], v. 85, n. 4, p. 585-586, 2022.
Chicago: Author-Date Style
Sookaromdee, Pathum, and Viroj Wiwanitkit. 2022. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS.” İstanbul Tıp Fakültesi Dergisi 85, no. 4: 585-586. https://doi.org/10.26650/IUITFD.1133431
Chicago: Humanities Style
Sookaromdee, Pathum, and Viroj Wiwanitkit. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS.” İstanbul Tıp Fakültesi Dergisi 85, no. 4 (Nov. 2024): 585-586. https://doi.org/10.26650/IUITFD.1133431
Harvard: Australian Style
Sookaromdee, P & Wiwanitkit, V 2022, 'THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS', İstanbul Tıp Fakültesi Dergisi, vol. 85, no. 4, pp. 585-586, viewed 18 Nov. 2024, https://doi.org/10.26650/IUITFD.1133431
Harvard: Author-Date Style
Sookaromdee, P. and Wiwanitkit, V. (2022) ‘THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS’, İstanbul Tıp Fakültesi Dergisi, 85(4), pp. 585-586. https://doi.org/10.26650/IUITFD.1133431 (18 Nov. 2024).
MLA
Sookaromdee, Pathum, and Viroj Wiwanitkit. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS.” İstanbul Tıp Fakültesi Dergisi, vol. 85, no. 4, 2022, pp. 585-586. [Database Container], https://doi.org/10.26650/IUITFD.1133431
Vancouver
Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İstanbul Tıp Fakültesi Dergisi [Internet]. 18 Nov. 2024 [cited 18 Nov. 2024];85(4):585-586. Available from: https://doi.org/10.26650/IUITFD.1133431 doi: 10.26650/IUITFD.1133431
ISNAD
Sookaromdee, Pathum - Wiwanitkit, Viroj. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”. İstanbul Tıp Fakültesi Dergisi 85/4 (Nov. 2024): 585-586. https://doi.org/10.26650/IUITFD.1133431
